Surgery Partners, Inc. $SGRY Shares Purchased by Wellington Management Group LLP

Wellington Management Group LLP raised its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 19.7% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,091,756 shares of the company’s stock after purchasing an additional 1,165,667 shares during the quarter. Wellington Management Group LLP owned about 5.53% of Surgery Partners worth $168,429,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Janus Henderson Group PLC boosted its stake in Surgery Partners by 110.2% during the fourth quarter. Janus Henderson Group PLC now owns 11,554,845 shares of the company’s stock valued at $244,616,000 after buying an additional 6,057,477 shares in the last quarter. King Street Capital Management L.P. boosted its position in shares of Surgery Partners by 93.1% during the 4th quarter. King Street Capital Management L.P. now owns 2,800,000 shares of the company’s stock valued at $59,276,000 after purchasing an additional 1,350,000 shares in the last quarter. Point72 Asset Management L.P. grew its stake in shares of Surgery Partners by 224.7% in the 4th quarter. Point72 Asset Management L.P. now owns 1,746,554 shares of the company’s stock worth $36,975,000 after purchasing an additional 1,208,639 shares during the last quarter. Alpine Associates Management Inc. acquired a new position in shares of Surgery Partners in the 1st quarter worth approximately $13,539,000. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Surgery Partners by 18.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company’s stock worth $75,739,000 after purchasing an additional 563,812 shares in the last quarter.

Surgery Partners Trading Up 2.8%

Surgery Partners stock opened at $23.84 on Thursday. Surgery Partners, Inc. has a 52 week low of $18.87 and a 52 week high of $33.97. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.78 and a current ratio of 1.93. The firm has a market capitalization of $3.06 billion, a price-to-earnings ratio of -16.67 and a beta of 1.82. The company has a 50 day moving average price of $22.12 and a 200 day moving average price of $22.94.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The company had revenue of $826.20 million during the quarter, compared to analyst estimates of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The company’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.21 earnings per share. Research analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on SGRY. Barclays reduced their target price on shares of Surgery Partners from $25.00 to $24.00 and set an “equal weight” rating for the company in a report on Tuesday, May 27th. Bank of America started coverage on Surgery Partners in a research note on Monday, July 28th. They set a “buy” rating and a $28.00 price objective for the company. Six analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Surgery Partners currently has an average rating of “Moderate Buy” and a consensus target price of $33.00.

Insider Buying and Selling

In other Surgery Partners news, Director Teresa Deluca sold 20,018 shares of the firm’s stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $22.74, for a total transaction of $455,209.32. Following the completion of the sale, the director directly owned 45,173 shares in the company, valued at approximately $1,027,234.02. This trade represents a 30.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 2.70% of the company’s stock.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.